SCHEMBL4989356

SCHEMBL4989356

NC(=O)c1n[c]c2c(n1)CN(C(=O)Cc1ccccc1)CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
KMT2A Q03164 2/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.42
RAB9A P51151 1/20 0.40
USP2 O75604 1/20 0.40
GAA P10253 1/20 0.40
ALDH1A1 P00352 5/20 0.39
POLB P06746 1/20 0.39
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSD11B1 P28845 1/20 0.39
GPBAR1 Q8TDU6 1/20 0.39
MEN1 O00255 1/20 0.38
KCNK3 O14649 1/20 0.38
TSHR P16473 1/20 0.38
GRM5 P41594 1/20 0.37
KDR P35968 1/20 0.37
GBA1 P04062 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4986045 0.89 POLB (0.42) NPC1KMT2ARAB9AUSP2ALDH1A1
SCHEMBL4990959 0.86 SMN1; SMN2 (0.50) KMT2ARAB9AGAAALDH1A1L3MBTL1
SCHEMBL4983019 0.85 SIGMAR1 (0.47) NPC1KMT2AGAAALDH1A1POLB
SCHEMBL4980948 0.85 MEN1 (0.49) NPC1KMT2ARAB9AUSP2GAA
SCHEMBL4985620 0.83 PTGS1 (0.43) PTGDR2TSHRGRM5
SCHEMBL4983744 0.83 HTT (0.49) NPC1KMT2AALDH1A1MEN1KDM4E
SCHEMBL4984714 0.82 KMT2A (0.44) NPC1KMT2ARAB9AGAAALDH1A1
SCHEMBL4984695 0.81 GRM5 (0.38) NPC1RAB9AGPBAR1GRM5
SCHEMBL4989567 0.80 TSHR (0.39) KMT2AALDH1A1MEN1TSHRKDM4E
SCHEMBL4988789 0.79 CNR2 (0.44) KMT2ARAB9AGAAALDH1A1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 NPC1 2233/4885KMT2A 4614/4885PTGDR2 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.